Cargando…

Prevalence of sexually transmitted diseases in female athletes in São Paulo, Brazil

OBJECTIVE: To determine the prevalence of sexually transmitted diseases in female athletes. METHODS: An observational, cross-sectional study was conducted including 50 female athletes with mean age of 20±3 years. Colposcopy, pap smear, and polymerase chain reaction for Chlamydia trachomatis, human p...

Descripción completa

Detalles Bibliográficos
Autores principales: de Araujo, Maíta Poli, Kleine, Henrique Truffa, Parmigiano, Tathiana Rebizzi, Gomes, Natalia Tavares, Caparroz, Graziela Pascom, da Silva, Ismael Dale Cotrim Guerreiro, Girão, Manoel João Batista Castello, Sartori, Marair Gracio Ferreira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898236/
https://www.ncbi.nlm.nih.gov/pubmed/24728243
http://dx.doi.org/10.1590/S1679-45082014AO2949
Descripción
Sumario:OBJECTIVE: To determine the prevalence of sexually transmitted diseases in female athletes. METHODS: An observational, cross-sectional study was conducted including 50 female athletes with mean age of 20±3 years. Colposcopy, pap smear, and polymerase chain reaction for Chlamydia trachomatis, human papillomavirus and Neisseria gonorrhoeae were performed. Blood samples were collected to test for the human immunodeficiency virus, syphilis, hepatitis B and C. The athletes presenting clinical diseases or conditions identifiable by laboratory tests were treated and followed up in the unit. RESULTS: Forty-six percent of the participants were unaware of sexually transmitted diseases. The prevalence of sexually transmitted diseases among athletes was 48% (24 cases). Human papillomavirus was the most frequent agent (44%). Considering the human papillomavirus genotypes, subtype 16 was the most prevalent (53%), followed by 11-6 (22%) and 18 (13%). Two athletes tested positive for C. trachomatis. There were no cases diagnosed of infection by N. gonorrhoeae, syphilis, hepatitis B, hepatitis C and human immunodeficiency virus. However, only 26 athletes had been vaccinated for hepatitis B. CONCLUSION: The prevalence of sexually transmitted diseases in female athletes was high. Primary prevention measures (hepatitis B and human papillomavirus vaccination) and secondary (serology, pap smears) must be offered to this specific group of women. The matter should be further approached in sports.